CBLL (CeriBell) Net Interest Income: $-1.8 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CBLL CeriBell Inc CBLL
12 GF Score
Price $23.34
! 4 Warning Signs
View Full Analysis

What is CeriBell Net Interest Income?

CeriBell CBLL +0.39% 12 Net Interest Income is $-1.8 Mil as of Jun. 2026. GuruFocus rates CBLL with a GF Score™ of 12/100. The stock has 4 warning signs investors should review.

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. CeriBell's net interest income for the three months ended in Jun. 2026 was $-0.4 Mil. Its net interest income for the trailing twelve months (TTM) ended in Jun. 2026 was $-1.8 Mil.


CeriBell Net Interest Income Related Terms


CeriBell Net Interest Income Historical Data

* Premium members only.

The historical data trend for CeriBell's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CeriBell Net Interest Income Chart

CeriBell Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Net Interest Income
-1.60 -2.10 -1.99 -1.89

CeriBell Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.48 -0.48 -0.46 -0.43 -0.44
CBLL
12GF Score
CeriBell Inc CBLL
Net Interest Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CeriBell Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Interest Income →
What does a Net Interest Income of $-1.8 Mil mean?
CeriBell (CBLL) has a Net Interest Income of $-1.8 Mil as of Jun. 2026.
Is CeriBell's Net Interest Income too high?
CeriBell's current Net Interest Income is $-1.8 Mil. Overall, CeriBell has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does CeriBell's Net Interest Income compare to TCMD and CERS?
CeriBell's Net Interest Income of $-1.8 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Interest Income for a Medical Devices & Instruments company?
A good Net Interest Income depends on the Medical Devices & Instruments industry context. However, Net Interest Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Interest Income mean?
A high Net Interest Income can signal that a stock is expensive relative to its fundamentals. CeriBell's current Net Interest Income is $-1.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CeriBell stock overvalued right now?
CeriBell (CBLL) has a current Net Interest Income of $-1.8 Mil. The current Net Interest Income is $-1.8 Mil. CeriBell's overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Interest Income calculated?
Net Interest Income is calculated from a company's financial statements. For CeriBell (CBLL), the current Net Interest Income is $-1.8 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CeriBell Business Description

Other Exchanges W3H:Germany
Address 360 N. Pastoria Avenue, Sunnyvale, CA, USA, 94085
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
12GF Score

Get the complete analysis for CBLL

Net Interest Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.34
Price